MOREGOLA, ANNALISA
MOREGOLA, ANNALISA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Development of a human immune system experimental model to investigate immune cells activation and targeting for CVD
2026 A. Moretti, S. Greco, A. Moregola, S. Della Bella, S. Balin, G.B. Vingiani, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Cocaine exposure during adolescence impairs stress induced behavioral and immune responses
2026 P. Miglioranza, L. Da Dalt, S. Parolaro, B. Rizzi, S. Taddini, A. Moregola, G.D. Norata, L. Caffino, F. Fumagalli, F. Mottarlini
SREBP1c Modulates Treg Immunobiology Through a Phospholipid-Dependent Adenosine Pathway
2026 F. Bonacina, C. Procaccini, M. Iaia, A. Moretti, M. Svecla, S. Pedretti, J. Bogie, G.B. Vingiani, A. Moregola, F. Genova, C. Russo, G.D. Rosa, C.L. Rocca, G. Mondanelli, M. Gargaro, N. Mitro, G. Matarese, G.D. Norata
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.B. Vingiani, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.B. Vingiani, L. Gulla', M. Iaia, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.D. Norata, F. Bonacina
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Increased mitochondrial fusion via systemic OPA1 overexpression promotes dyslipidemia and atherosclerosis in LDLR deficient mice
2025 L. Da Dalt, F. Fantini, G. Giancane, A. Moregola, S. Roda, M. Svecla, S. Pedretti, G.B. Vingiani, J. Sun, A. Edsfeldt, I. Goncalves, P. Uboldi, E. Donetti, A. Baragetti, N. Mitro, L. Scorrano, G.D. Norata
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, G. Biagioli, J. Bojie, G.D. Norata, F. Bonacina
Profiling the impact of anti-human CD20 monoclonal antibodies on lymphocyte B cell subsets and their precursors in the bone marrow and in lymphoid tissues in an immunocompromised mouse engrafted with human cells
2024 A. Moregola, F. Bonacina, G.B. Vingiani, R. Frapolli, R. Turrini, G.D. Norata
Role of STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) in the metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, G.D. Norata, F. Bonacina
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, J. Bojie, G.D. Norata, F. Bonacina
Engineering stem cells for immunomodulatory cell therapy of cardiovascular diseases
2024 A. Moretti, S. Greco, G.B. Vingiani, A. Moregola, E. Franchi, M. Busnelli, G.D. Norata, F. Bonacina
Engineering stem cells for immunomodulatory cell therapy of cardiovascular diseases
2024 A. Moretti, S. Greco, A. Moregola, E. Franchi, M. Busnelli, G.D. Norata, F. Bonacina
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, G. Biagioli, J. Bojie, G.D. Norata, F. Bonacina
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity
2024 M. Svecla, L. Da Dalt, A. Moregola, J. Nour, A. Baragetti, P. Uboldi, E. Donetti, L. Arnaboldi, G. Beretta, F. Bonacina, G.D. Norata
ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice
2024 M. Svecla, A. Moregola, L.D. Dalt, J. Nour, A. Baragetti, P. Uboldi, A. Idini, M. Wuhrer, G. Beretta, D. Falck, F. Bonacina, G.D. Norata